Pages that link to "Q44124436"
Jump to navigation
Jump to search
The following pages link to Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. (Q44124436):
Displaying 50 items.
- T cell avidity and tumor recognition: implications and therapeutic strategies (Q24815775) (← links)
- Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro (Q25257888) (← links)
- Understanding the role of the kynurenine pathway in human breast cancer immunobiology (Q26773472) (← links)
- Targeting amino acid metabolism in cancer growth and anti-tumor immune response (Q26775425) (← links)
- The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity (Q26785900) (← links)
- The role of IDO in brain tumor immunotherapy (Q26830399) (← links)
- Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention (Q26850218) (← links)
- Trial watch: IDO inhibitors in cancer therapy (Q27006866) (← links)
- The blockade of immune checkpoints in cancer immunotherapy (Q27860852) (← links)
- 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity (Q27863347) (← links)
- Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase (Q28204166) (← links)
- IL4I1: an inhibitor of the CD8+ antitumor T‐cell response in vivo (Q28389817) (← links)
- IDO expression by dendritic cells: tolerance and tryptophan catabolism (Q29614752) (← links)
- Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy (Q30410002) (← links)
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectors (Q30433292) (← links)
- Decreased IDO Activity and Increased TTS Expression Break Immune Tolerance in Patients with Immune Thrombocytopenia (Q33394889) (← links)
- Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer (Q33482453) (← links)
- Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets (Q33731047) (← links)
- Combination of physical activity, nutrition, or other metabolic factors and vaccine response (Q33751144) (← links)
- Anti-HER2 vaccines: new prospects for breast cancer therapy (Q34105959) (← links)
- Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. (Q34314847) (← links)
- Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. (Q34394487) (← links)
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer (Q34414152) (← links)
- A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors (Q34483473) (← links)
- Big opportunities for small molecules in immuno-oncology (Q34487689) (← links)
- Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. (Q34550440) (← links)
- System in biology leading to cell pathology: stable protein-protein interactions after covalent modifications by small molecules or in transgenic cells (Q34564273) (← links)
- Immunoregulatory effects of indoleamine 2, 3-dioxygenase in transplantation (Q34609461) (← links)
- Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. (Q34655953) (← links)
- Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2 (Q34669312) (← links)
- Immune escape as a fundamental trait of cancer: focus on IDO. (Q34758085) (← links)
- Sunitinib indirectly enhanced anti-tumor cytotoxicity of cytokine-induced killer cells and CD3⁺CD56⁺ subset through the co-culturing dendritic cells (Q35043102) (← links)
- Cancer vaccines: between the idea and the reality (Q35219026) (← links)
- Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression (Q35583214) (← links)
- Molecular basis for the substrate stereoselectivity in tryptophan dioxygenase (Q35613409) (← links)
- HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells (Q35751070) (← links)
- Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs (Q35757397) (← links)
- Immunity, cancer and aging: lessons from mouse models. (Q35806782) (← links)
- The role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infection (Q35808796) (← links)
- Complete reaction mechanism of indoleamine 2,3-dioxygenase as revealed by QM/MM simulations. (Q35832639) (← links)
- Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. (Q35835489) (← links)
- Challenges and future perspectives of T cell immunotherapy in cancer (Q35843507) (← links)
- Cancer vaccine development: on the way to break immune tolerance to malignant cells. (Q35879344) (← links)
- Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases (Q35952614) (← links)
- Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation (Q35986384) (← links)
- Metabolic mechanisms of tumor resistance to T cell effector function (Q36075227) (← links)
- Identification of Interferon-Stimulated Genes with Antiretroviral Activity (Q36134164) (← links)
- Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors. (Q36219738) (← links)
- Transcriptional regulation of indoleamine 2,3-dioxygenase (IDO) by tryptophan and its analogue : Down-regulation of the indoleamine 2,3-dioxygenase (IDO) transcription by tryptophan and its analogue. (Q36495616) (← links)
- Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer (Q36612457) (← links)